Chia Nan University of Pharmacy & Science Institutional Repository:Item 310902800/34557
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 18272/20499 (89%)
Visitors : 13306532      Online Users : 972
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    請使用永久網址來引用或連結此文件: https://ir.cnu.edu.tw/handle/310902800/34557


    題名: Angiogenesis Driven by the CEBPD-hsa-miR-429-VEGFA Signaling Axis Promotes Urothelial Carcinoma Progression
    作者: Chan, Ti-Chun
    Hsing, Chung-Hsi
    Shiue, Yow-Ling
    Huang, Steven K.
    Hsieh, Kun-Lin
    Kuo, Yu-Hsuan
    Li, Chien-Feng
    貢獻者: Chi Mei Hospital
    National Health Research Institutes - Taiwan
    National Sun Yat Sen University
    Department of Biotechnology, Chia Nan University of Pharmacy & Science
    College of Pharmacy and Science, Chia Nan University of Pharmacy & Science
    關鍵詞: endothelial growth-factor
    targeted therapy
    c/ebp-delta
    cancer
    bevacizumab
    inhibition
    resistance
    cisplatin
    vegfa
    日期: 2022
    上傳時間: 2023-12-11 13:57:44 (UTC+8)
    出版者: MDPI
    摘要: Background and Purpose: This research aimed to excavate the alternative mechanism of CEBPD on tumor growth and explore the biological significance of the CEBPD/hsa-miR-429/VEGFA axis on angiogenesis in urothelial carcinoma (UC). Methods: Quantitative RT-PCR, immunoblotting assay and tube formation examined the effect of hsa-miR-429 mimic or/and inhibitor on VEGFA expression and angiogenesis in CEBPD-overexpressing UC-derived cells. The association between CEBPD, hsa-miR-429, VEGFA and microvascular density (MVD) and clinical outcome were evaluated in 296 patients with UBUC and 340 patients with UTUC, respectively. Results: The increase in the transcript and protein of VEGFA as well as HUVECs tube formation was diminished upon the treatment of hsa-miR-429 mimic in CEBPD-overexpressing BFTC909 and TCCSUP. Nevertheless, the inhibited regulation of hsa-miR-429 mimic on the expression of VEGFA and ability of HUVECs tube formation was rescued by the combined incubation with hsa-miR-429 inhibitor in these two UC-derived cell lines. Furthermore, the clinical correlations showed that the higher level of VEGFA or MVD has a positive correlation with the expression of CEBPD and a negative relation to hsa-miR-429 and leads to tumor aggressiveness with worse disease-specific, metastasis-free survival in UBUC and UTUC cohorts. Conclusions: We decipher the oncogenic mechanism of CEBPD on angiogenesis through the hsa-miR-429 inhibition to stabilize the expression of VEGFA in UC. The novel research unveiled the modulation of the CEBPD/hsa-miR-429/VEGFA axis on the progression of UC and could be accessible to theranostic biomarkers.
    關聯: CELLS, v.11, n.4, 638
    顯示於類別:[Dept. of Biotechnology (including master's program)] Periodical Articles
    [Dept. of Cosmetic Science and institute of cosmetic science] Periodical Articles

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    cells-11-00638-v2.pdf2569KbAdobe PDF196檢視/開啟
    index.html0KbHTML491檢視/開啟


    在CNU IR中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback